PharmaVOICE
- May 2009
Last Word
For Clayton Christensen, disruption can be both a threat and an opportunity — it all depends how a company frames it. In general, though, Mr. Christensen views disruptive innovation as a huge growth opportunity for the pharmaceutical industry.
Mr. Christensen believes the changing dynamics of the healthcare industry mean companies need to rethink their models and focus on their core critical competencies — discovery, development, and clinical research.
WHAT’S THIS?
PDF: Single-user watermarked PDF file. Copyright protected for your review only. This file cannot be used as a promotional or educational
piece. If you are interested in an E-Print, request a Reprint Quote for pricing.
*Downloaded PDF files are not returnable or refundable.
Reprint: A hard-copy reproduction of a specific article printed for promotional or educational use. These are printed in quantities of
100 to 2,500.
Back Issue: A printed copy of an entire magazine. These are sold in unlimited quantities. |
|
